Related Experiment Video
Updated: Sep 15, 2025

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
Multiple Long-Term Conditions, Co-Long-Term Conditions and Polyvascular Disease: Considerations for Evidence
Gillian Mead1, Alex Todhunter-Brown2, Ukachukwu Abaraogu3,4
1Usher Institute, University of Edinburgh Edinburgh UK.
Insights
This article introduces
Area of Science:
- Medical Research
- Systematic Reviews
- Public Health
Background:
- Cochrane's 2025-2030 strategy prioritizes improving lives of individuals with multiple chronic conditions.
- Existing systematic reviews may not adequately address the complexities of multiple long-term conditions.
Purpose of the Study:
- To explore considerations for multiple chronic conditions in systematic reviews.
- To propose the term 'co-long-term conditions' to replace 'comorbidity'.
- To define 'polyvascular disease' within the context of systematic reviews.
Main Methods:
- Literature review and expert discussion by the Cochrane Thematic Group in Heart, Stroke and Circulation.
- Analysis of current practices in systematic reviews concerning multiple long-term conditions.
- Development of recommendations for review authors.
Main Results:
- The term 'co-long-term conditions' is proposed for clarity.
- Guidance is offered on defining 'polyvascular disease'.
- Specific recommendations are made for data extraction, subgroup analyses, and discussion sections in systematic reviews.
Conclusions:
- Systematic reviews should explicitly address co-long-term conditions.
- Enhanced methodology will improve the representation of individuals with multiple conditions in research.
- This approach is crucial for reviews on heart, circulatory, and stroke diseases, including polyvascular disease.
Abstract:
Cochrane's scientific strategy for 2025 to 2030 has four research priorities, including improving the lives of people living with multiple chronic conditions. The purpose of this article written by the Cochrane Thematic Group in Heart, Stroke and Circulation is to explore considerations around multiple chronic conditions (also referred to as 'multiple long-term conditions' i.e. two or more long-term conditions) in systematic reviews. Rather than using the term 'comorbidity', we introduce a new term 'co-long-term conditions'. We also explore how to define 'polyvascular disease'. We suggest that review authors consider co-long-term conditions and multiple long-term conditions in their reviews e.g. extract data about how primary studies address co-long-term conditions, perform subgroup analyses according to presence or not of co-long-term conditions, and include a section in the discussion about how well participants with co-long-term conditions were represented in the primary studies. This is especially pertinent for reviews addressing heart, circulatory or stroke disease, and polyvascular disease.
More Related Videos
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Longitudinal Studies
Longitudinal Research
Hypertension III: Clinical Manifestations and Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Rheumatic Heart Disease III: Medical Management
Introduction to Epidemiology